Khiron enters exclusive distribution agreement with RAPPI

Khiron Life Sciences Corp. announced today that it has entered into an exclusive distribution agreement with Rappi SAS, the leading Latin American last-mile multi-vertical platform that is backed with a $1 billion investment from Softbank Group Corp. and Softbank Vision Fund. The expansive agreement comprises a 6-month exclusive distribution partnership between Rappi and Khiron to introduce and distribute the Company’s CPG product portfolio across Latin America through the Rappi platform.

Source: PR Newswire